ACI: Pharma & Biotech Patent Litigation USA
As pharma and biotech litigation becomes more complex, Patlytics gives litigators one platform to track invalidity, infringement, and prior art across multiple jurisdictions.
ACI Pharma & Biotech Patent Litigation USA & Canada is where pharma and biotech patent litigators are headed to compare concerns, strategies, and trends from the life sciences and IP field.
Patlytics is showing up to hear firsthand what teams need from AI in life science workflows. It's a valuable chance to meet with IP teams from across the continent and discuss what Patlytics offers.
Know your exposure
Run invalidity and infringement analysis on your own portfolio before a dispute ever starts so litigation strategy begins with answers, not a scramble
Chemical structures and sequences, drafted natively
Draw chemical structures, define Markush groups, and draft from biological sequences directly in the workspace with FDA Orange Book and Purple Book data built in. Trusted by Sanofi and GRAIL.
Built for scrutiny, not just speed
99%+ excerpt accuracy and ~99% citation matching.
Will you be at ACI: Pharma & Biotech Patent Litigation USA & Canada?
Schedule a time to meet with us during the event.

Candice brings a practitioner's lens to Patlytics, drawing on her experience as an IP litigator representing leading companies and executives across the pharmaceutical, high-tech, automotive, consumer products, media, fashion, and retail industries. Before joining Patlytics, Candice spent nearly a decade as an IP litigation attorney at Steptoe, appearing before U.S. federal district courts, U.S. courts of appeals, and the Patent Trial and Appeal Board (PTAB).